Meagan Parrish
Lead Editor | LinkedInMeagan Parrish is the lead editor for PharmaVoice. She got her professional start as an editor at a women’s magazine in her current home of Madison, Wisconsin, before jumping into B2B industry reporting. She spent three years covering the chemicals, energy, food and healthcare sectors at numerous publications, and then became a full-time pharma journalist. During her four years as senior editor at Pharma Manufacturing, Meagan was a three-time Neal Awards finalist, and was honored to receive numerous other accolades for her industry reporting. Her highest honor was the Stephen Barr Award, a prestigious “best in show” award chosen from the 2020 pool of Gold-winning articles by the American Society of Business Publication Editors (ASBPE) for her coverage of contaminated APIs in drugs imported from overseas. Pharma Manufacturing also snagged the 2021 Magazine of the Year award from ASBPE. Meagan joined PharmaVoice in late 2021 after the publication was acquired by Industry Dive and relaunched as a daily digital. But Meagan’s most important job is being Mom to her two daughters and teaching them to cook, dance and talk in funny accents.
182 articles by Meagan Parrish
-
Beyond dire wolves: Could Colossal’s de-extinction work transform human health?
Oct. 10, 2025 -
With Emma Walmsley exiting GSK, who will be pharma’s top women CEOs?
Oct. 3, 2025 -
Top pharma industry conferences in 2026
Oct. 1, 2025 -
Is pharma’s IRA pricing battle running out of steam?
Sept. 26, 2025 -
3 FDA approval firsts that could be around the corner
Sept. 19, 2025 -
4 years from clinic to approval — Precigen’s ‘unprecedented’ FDA nod and what comes next
Sept. 12, 2025 -
And just like that... pharma’s breakups reveal pain points in cancer R&D
Aug. 22, 2025 -
As gene therapies falter on the market, this biopharma is aiming to defy the odds
Aug. 8, 2025 -
C-suite shuffles ripple through pharma
July 31, 2025 -
Pharma’s turbo spending spree on US manufacturing
July 24, 2025 -
Who is Dr. George Tidmarsh, the new director of CDER?
July 23, 2025 -
Why FDA’s CRL release could open the door to lawsuits against pharma
July 18, 2025 -
Early measles drug R&D kicks into gear as U.S. records record outbreak
July 11, 2025 -
3 of the year’s most notable FDA nods
June 27, 2025 -
How a patient group tackled research diversity for one disease and triggered change for pharma
June 17, 2025 -
A day in the life of GSK’s U.S. president
June 13, 2025 -
Biotech CEO confidence hits rock bottom amid policy shifts
June 4, 2025 -
AbbVie’s ADC win shows how pharma can break through in solid tumors
May 30, 2025 -
A startup with Theranos ties has another blood test in the works. This time, competition is waiting.
May 16, 2025 -
AI is already delivering pharma value — and not just in drug discovery
May 12, 2025 -
Is pharma ready to let go of animal testing?
May 2, 2025 -
What’s being cut at NIH
April 25, 2025 -
A big moment is coming for psychedelics
April 18, 2025 -
Pharma’s US manufacturing moment: Where companies are making the biggest moves
April 11, 2025 -
The year’s biggest biotech haul shows investors are still chasing the AI dream
April 4, 2025